COMPARISON OF THE EFFECT OF TOPICAL BROMFENAC AND TOPICAL FLURBIPROFEN IN MAINTAINING MYDRIASIS DURING CATARACT SURGERY
Journal: Indian Drugs (Vol.57, No. 12)Publication Date: 2021-04-10
Authors : T.H. Deepika N.G. Chandan; T.R. Manjula;
Page : 56-60
Keywords : * For Correspondence: E-mail: drchandanng81@yahoo.com;
Abstract
At the time of cataract surgery, one of the challenges a surgeon encounters is intraoperative miosis. This might increase the chances of intraoperative and postoperative complications. Thus, maintainence of adequate pupillary dilatation is necessary during cataract surgery. Aim of the study was to compare the effectiveness of prophylactic administration of topical bromfenac (0.09 % w/V) and topical flurbiprofen (0.03 % w/V) in maintaining mydriasis during the cataract surgery. A total of 100 patients were randomly divided into two groups of 50 each. Group 1 received topical bromfenac (0.09 %) and Group 2 received topical flurbiprofen (0.03 %). The mean percentage loss of mydriasis from the baseline was lesser in bromfenac group compared to flurbiprofen group (p < 0.001). Topical bromfenac was found to be more effective in maintaining mydriasis during the cataract surgery when compared to the topical flurbiprofen.
Other Latest Articles
- ENHANCED ANTI-INFLAMMATORY AND ANTI-MIGRATORY EFFECT OF HERBAL NANO-STATINS ON HEPG2 CANCER CELLS
- ANTI-DIABESITY PRINCIPLE FROM THE SEEDS OF PHYLLANTHUS EMBLICA L
- DEVELOPMENT AND METHOD VALIDATION OF STABILITY INDICATING ASSAY METHOD OF DUTASTERIDE BY USING UV-VIS SPECTROSCOPY
- RATIONAL DESIGN, SYNTHESIS AND IN VITRO EVALUATION OF N-(4-ETHOXYPHENYLSULFONYL)-L-GLUTAMIC ACID ANALOGUES AS ANTIANGIOGENIC AND ANTICANCER AGENTS ON MULTIPLE MYELOMA
- NON-STEROIDAL HUMAN PERFORMANCE ENHANCING AGENTS
Last modified: 2021-07-31 20:32:24